GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiuzhitang Co Ltd (SZSE:000989) » Definitions » EBIT

Jiuzhitang Co (SZSE:000989) EBIT : ¥255 Mil (TTM As of Dec. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Jiuzhitang Co EBIT?

Jiuzhitang Co's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2024 was ¥-35 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was ¥255 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Jiuzhitang Co's annualized ROC % for the quarter that ended in Dec. 2024 was -2.69%. Jiuzhitang Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was -8.26%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Jiuzhitang Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 3.95%.


Jiuzhitang Co EBIT Historical Data

The historical data trend for Jiuzhitang Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiuzhitang Co EBIT Chart

Jiuzhitang Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 352.00 363.74 458.47 354.21 254.87

Jiuzhitang Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.42 179.64 65.25 44.72 -34.74

Competitive Comparison of Jiuzhitang Co's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Jiuzhitang Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiuzhitang Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jiuzhitang Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Jiuzhitang Co's EV-to-EBIT falls into.


;
;

Jiuzhitang Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥255 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiuzhitang Co  (SZSE:000989) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Jiuzhitang Co's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

ROC % (Q: Dec. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2024 ) + Invested Capital (Q: Dec. 2024 ))/ count )
=-135.504 * ( 1 - 30.49% )/( (3628.752 + 3364.751)/ 2 )
=-94.1888304/3496.7515
=-2.69 %

where

Invested Capital(Q: Sep. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=5262.652 - 1126.539 - ( 507.361 - max(0, 1394.687 - 2837.044+507.361))
=3628.752

Invested Capital(Q: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=5211.441 - 953.81 - ( 892.88 - max(0, 1139.557 - 2860.413+892.88))
=3364.751

Note: The Operating Income data used here is four times the quarterly (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Jiuzhitang Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2024  Q: Dec. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-138.964/( ( (1160.046 + max(492.5, 0)) + (1271.358 + max(439.817, 0)) )/ 2 )
=-138.964/( ( 1652.546 + 1711.175 )/ 2 )
=-138.964/1681.8605
=-8.26 %

where Working Capital is:

Working Capital(Q: Sep. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(747.643 + 948.1 + 61.953) - (1126.539 + 0 + 138.657)
=492.5

Working Capital(Q: Dec. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(392.917 + 1061.844 + 79.242) - (953.81 + 0 + 140.376)
=439.817

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Jiuzhitang Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2024 )
=254.865/6459.169
=3.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jiuzhitang Co EBIT Related Terms

Thank you for viewing the detailed overview of Jiuzhitang Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiuzhitang Co Business Description

Traded in Other Exchanges
N/A
Address
No. 339 Tongzipo West Road, Tonglu, Hunan province, Changsha, CHN, 410205
Jiuzhitang Co Ltd is a China-based medicine company. It is engaged in the manufacture and sale of traditional Chinese medicines and biological medicine. The company developed four different lines of products such as Health Products, Modern Chinese Medicine, Ecological Western Medicine and Biomedical Medicine. The organization sells its products in China and international countries.
Executives
Li Zhen Guo Director
Liu Guo Chao Director
Xu Xiang Ping Directors, executives
Liu Shu Xia Supervisors
Sun Wei Xiang Executives
Sheng Suo Zhu Directors, executives
Yang Lian Min Executives
Gao Jin Yan Executives
Sun Xiao Bo Director
Xu De An Supervisors
Cai Guang Yun Executives
Yu Ke Jian Director

Jiuzhitang Co Headlines

No Headlines